Kerim Babaoglu

Kerim Babaoglu currently holds the position of Senior Director at Morphic Therapeutic. Previously, Kerim Babaoglu served as a Director, Principal Scientist at Merck, and Research Scientist II specializing in Structural Chemistry at Gilead Sciences. Additionally, Kerim Babaoglu completed a Post Doctoral Fellowship at UCSF, contributing significant expertise in scientific research and development throughout an extensive career in the pharmaceutical industry.